Ignite Creation Date:
2025-12-25 @ 2:52 AM
Ignite Modification Date:
2026-05-17 @ 4:18 PM
Study NCT ID:
NCT02383433
Status:
TERMINATED
Last Update Posted:
2023-10-23
First Post:
2015-03-04
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Regorafenib Plus Gemcitabine in Metastatic Pancreatic Cancer
Sponsor:
Case Comprehensive Cancer Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CASE5214
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |